News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,142 Results
Type
Article (14251)
Company Profile (281)
Press Release (253610)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79534)
Career Advice (152)
Deals (13231)
Drug Delivery (35)
Drug Development (50462)
Employer Resources (31)
FDA (5724)
Job Trends (5133)
News (144439)
Policy (10033)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21674)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5752)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1481)
Cardiovascular disease (117)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (8)
Clinical research (41088)
Collaboration (542)
Compensation (260)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1525)
Denatured (11)
Depression (30)
Diabetes (139)
Diagnostics (1300)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29849)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48614)
Executive appointments (464)
FDA (6425)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1080)
Grass and pollen (2)
Guidances (23)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7274)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1387)
Liver cancer (33)
Lung cancer (205)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (53)
Medical device (2599)
Medtech (2600)
Mergers & acquisitions (6289)
Metabolic disorders (390)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25650)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14514)
Phase II (19111)
Phase III (12082)
Pipeline (811)
Policy (45)
Postmarket research (852)
Preclinical (6141)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1420)
Recruiting (12)
Regulatory (8645)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1976)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (98)
Last 7 days (521)
Last 30 days (1533)
Last 365 days (19576)
2025 (6313)
2024 (20552)
2023 (22414)
2022 (26824)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7533)
2011 (7614)
2010 (7430)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17317)
Australia (2935)
California (3872)
Canada (1141)
China (361)
Colorado (149)
Connecticut (152)
Delaware (102)
Europe (37249)
Florida (467)
Georgia (117)
Idaho (16)
Illinois (232)
India (10)
Indiana (91)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (475)
Massachusetts (3086)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (970)
New Mexico (12)
New York (1046)
North Carolina (555)
North Dakota (5)
Northern California (1708)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (742)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1491)
Tennessee (25)
Texas (449)
United States (13295)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
268,142 Results for "evox therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
Evox Therapeutics Ltd, a leading exosome therapeutics company, announces that Dr. Per Lundin, Co-Founder and Chief Business Officer, has been appointed as Chief Executive Officer of the Company and will be appointed to its Board of Directors.
April 29, 2024
·
3 min read
Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform
Evox Therapeutics Ltd, a leading exosome therapeutics company, announced the publication in Nature Communications of Evox-funded research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes.
August 9, 2023
·
2 min read
Deals
Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property
Evox Therapeutics Ltd, a leading exosome therapeutics company, has purchased Codiak Biosciences engEx-AAV™ technology platform, including all intellectual property rights therein, as well as secured exclusive access to certain engineering and manufacturing rights associated with it.
June 20, 2023
·
2 min read
Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease
Evox Therapeutics Ltd, a leading exosome therapeutics company, announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai in New York, NY.
August 4, 2023
·
3 min read
Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio
Evox Therapeutics Ltd today announced that the Company has been granted another US patent adding to its growing manufacturing IP portfolio.
May 17, 2023
·
2 min read
Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics
Evox Therapeutics Ltd, a leading exosome therapeutics company, will present data at two upcoming international conferences: the American Society of Gene and Cell Therapy Annual Meeting, May 16-20, 2023, in Los Angeles, and the International Society for Extracellular Vesicles Annual Meeting, May 17-21, 2023, in Seattle.
May 12, 2023
·
4 min read
Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference
Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will participate in the 2022 Jefferies Healthcare Conference June 8-10, 2022. Antonin de Fougerolles, Ph.D., Chief Executive Officer of Evox Therapeutics, will present on Friday, June 10 at 11:30 a.m. EDT and will host 1x1 meetings at and around the conference in New York.
May 24, 2022
·
1 min read
Business
Evox Therapeutics Appoints Peter Jones as Vice President of CMC
Evox Therapeutics Ltd announces the appointment of Peter Jones as Vice President of CMC.
April 14, 2022
·
3 min read
Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced titles of nine abstracts to be presented as oral presentations and posters at the International Society for Extracellular Vesicles (ISEV) Annual Meeting, on May 25 to 29, 2022, in Lyon, France.
May 19, 2022
·
3 min read
Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform with Nine Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
Evox Therapeutics Ltd, a leading exosome therapeutics company, announced advances in exosome engineering, manufacturing and tissue targeting at the International Society for Extracellular Vesicles Annual Meeting, on May 25 to 29, 2022, in Lyon, France.
May 26, 2022
·
8 min read
1 of 26,815
Next
